Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy D Shae, KW Becker, P Christov, DS Yun, AKR Lytton-Jean, S Sevimli, ... Nature nanotechnology 14 (3), 269-278, 2019 | 518 | 2019 |
Metal limitation and toxicity at the interface between host and pathogen KW Becker, EP Skaar FEMS microbiology reviews 38 (6), 1235-1249, 2014 | 260 | 2014 |
Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines D Shae, JJ Baljon, M Wehbe, PP Christov, KW Becker, A Kumar, ... ACS nano 14 (8), 9904-9916, 2020 | 126 | 2020 |
Mucosal Immunization with a pH-Responsive Nanoparticle Vaccine Induces Protective CD8+ Lung-Resident Memory T Cells FC Knight, P Gilchuk, A Kumar, KW Becker, S Sevimli, ME Jacobson, ... ACS nano 13 (10), 10939-10960, 2019 | 108 | 2019 |
Genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii MI Hood, KW Becker, CM Roux, PM Dunman, EP Skaar Infection and immunity 81 (2), 542-551, 2013 | 95 | 2013 |
Poly (propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines F Qiu, KW Becker, FC Knight, JJ Baljon, S Sevimli, D Shae, P Gilchuk, ... Biomaterials 182, 82-91, 2018 | 91 | 2018 |
Nanoparticle delivery improves the pharmacokinetic properties of cyclic dinucleotide STING agonists to open a therapeutic window for intravenous administration M Wehbe, L Wang-Bishop, KW Becker, D Shae, JJ Baljon, X He, ... Journal of Controlled Release 330, 1118-1129, 2021 | 81 | 2021 |
Delivery of 5′-triphosphate RNA with endosomolytic nanoparticles potently activates RIG-I to improve cancer immunotherapy ME Jacobson, L Wang-Bishop, KW Becker, JT Wilson Biomaterials science 7 (2), 547-559, 2019 | 62 | 2019 |
Imaging mass spectrometry for assessing temporal proteomics: Analysis of calprotectin in Acinetobacter baumannii pulmonary infection JL Moore, KW Becker, JJ Nicklay, KL Boyd, EP Skaar, RM Caprioli Proteomics 14 (7-8), 820-828, 2014 | 57 | 2014 |
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy L Wang-Bishop, BR Kimmel, VM Ngwa, MZ Madden, JJ Baljon, ... Science Immunology 8 (83), eadd1153, 2023 | 32 | 2023 |
At the bench: Engineering the next generation of cancer vaccines D Shae, JJ Baljon, M Wehbe, KW Becker, TL Sheehy, JT Wilson Journal of Leucocyte Biology 108 (4), 1435-1453, 2020 | 30 | 2020 |
RAGE-mediated suppression of interleukin-10 results in enhanced mortality in a murine model of Acinetobacter baumannii sepsis MJ Noto, KW Becker, KL Boyd, AM Schmidt, EP Skaar Infection and immunity 85 (3), 10.1128/iai. 00954-16, 2017 | 28 | 2017 |
Structural Optimization of Polymeric Carriers to Enhance the Immunostimulatory Activity of Molecularly Defined RIG-I Agonists ME Jacobson, KW Becker, CR Palmer, LE Pastora, RB Fletcher, ... ACS central science 6 (11), 2008-2022, 2020 | 25 | 2020 |
A nanovaccine for enhancing cellular immunity via cytosolic co-delivery of antigen and polyIC RNA CS Carson, KW Becker, KM Garland, HM Pagendarm, PT Stone, K Arora, ... Journal of Controlled Release 345, 354-370, 2022 | 19 | 2022 |
Amphiphilic Polyelectrolyte Graft Copolymers Enhance the Activity of Cyclic Dinucleotide STING Agonists DC Nguyen, D Shae, HM Pagendarm, KW Becker, M Wehbe, KV Kilchrist, ... Advanced Healthcare Materials 10 (2), 2001056, 2021 | 18 | 2021 |
A cancer nanovaccine for co-delivery of peptide neoantigens and optimized combinations of STING and TLR4 agonists JJ Baljon, AJ Kwiatkowski, HM Pagendarm, PT Stone, A Kumar, V Bharti, ... ACS nano 18 (9), 6845-6862, 2024 | 7 | 2024 |
Nanoparticle Retinoic Acid-Inducible Gene I Agonist for Cancer Immunotherapy L Wang-Bishop, M Wehbe, LE Pastora, J Yang, BR Kimmel, KM Garland, ... ACS nano 18 (18), 11631-11643, 2024 | 1 | 2024 |